Here are some of the Top 2025 Ideas taken from RBC Capital's "Biotech Outlook" report:"REGN (Abrahams, Outperform, $1,215 price target) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE